The stock of Emerald Health Therapeutics Inc (CVE:EMH) is a huge mover today! About 549,065 shares traded hands. Emerald Health Therapeutics Inc (CVE:EMH) has risen 6.00% since November 1, 2016 and is uptrending. It has outperformed by 0.07% the S&P500.
The move comes after 8 months negative chart setup for the $87.20 million company. It was reported on Dec, 1 by Barchart.com. We have $1.32 PT which if reached, will make CVE:EMH worth $4.36M less.
More important recent Emerald Health Therapeutics Inc (CVE:EMH) news were published by: Marketwatch.com which released: “Emerald Health Therapeutics Announces Completion of Private Placement” on November 16, 2016, also Marketwatch.com published article titled: “Emerald Health Therapeutics Completes Private Placement and Shares for Debt …”, Finance.Yahoo.com published: “Emerald Announces Plans to Significantly Increase Cannabis Production with …” on November 29, 2016. More interesting news about Emerald Health Therapeutics Inc (CVE:EMH) was released by: Reuters.com and their article: “BRIEF-Emerald Health announces no material change” with publication date: May 30, 2016.
Emerald Health Therapeutics, Inc., formerly T-Bird Pharma Inc., is a Canada company, which through its subsidiary, Emerald Health Botanicals Inc. , is engaged in the production and sale of medical marihuana. The company has a market cap of $87.20 million. The Company’s segment is production and sales of medical marihuana pursuant to the Marihuana for Medical Purposes Regulations. It currently has negative earnings. Botanicals produces cannabis oils and capsules.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.